MedTrace Logo

Assessment of Patients Undergoing Cardiac Surgery and Admitted to the Intensive Care Unit

NCT06154473 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2023-12-04

No results posted yet for this study

Summary

The objective of this study is to investigate the incidence of death and early postoperative complications, identify potential risk factors, and examine the demographic characteristics of patients and epidemiology of cardiovascular procedures. Our hypothesis is that gaining a more comprehensive understanding of the characteristics of patients who undergo cardiac surgery has the potential to improve outcomes for this patient profile. Thus, information was sought regarding the patient characteristics, surgeries performed, anesthesia administered, incidence of intraoperative and postoperative complications, and risk factors associated with complication and mortality in the ICU. The main questions it aims to answer are:

* Incidence of mortality or severe postoperative complications that occur within the first 3 postoperative days or until discharge from the ICU.
* Risk factors associated with severe complications in patients who undergo cardiac surgery.
* Characteristics of patients, anesthesia and surgical procedures performed
* Incidence of severe intraoperative complications and moderate postoperative complications
* Evaluate the influence of accumulated fluid balance on outcomes, mortality, and length of ICU stay.
* Evaluate mortality in the ICU.
* Describe the risk factors associated with mortality.

Conditions

  • Cardiac Disease
  • Cardiac Ischemia
  • Cardiac Valve Disease

Interventions

PROCEDURE

Open heart surgery group.

Patients undergoing open heart surgery.

PROCEDURE

Percutaneous cardiovascular surgery group.

Patients undergoing percutaneous cardiovascular surgery.

Sponsors & Collaborators

  • Hospital Israelita Albert Einstein

    lead OTHER

Principal Investigators

  • Renato CF Chaves, MD, MBA. · Hospital Israelita Albert Einstein

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-01
Primary Completion
2024-09-30
Completion
2024-11-30

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06154473 on ClinicalTrials.gov